BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study
European Journal of Cancer2004Vol. 40(18), pp. 2788–2793
Citations Over TimeTop 16% of 2004 papers
Þórunn Rafnar, Kristrún R. Benediktsdóttir, Bjarki Eldon, Thorgeir Gestsson, Hafsteinn Saemundsson, Karl Olafsson, Anna Salvarsdottir, Eirı́kur Steingrı́msson, Steinunn Thorlacius
Related Papers
- → MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer(2017)55 cited
- → circKIF4A sponges miR-127 to promote ovarian cancer progression(2020)24 cited
- → Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnoses(2014)16 cited
- → Ovarian cancer : state of the art and future directions in translational research(2008)4 cited
- → Ovarian Cancer(2004)2 cited